 |  | About Chemagis |
| | Global Presence |
| | News & Events |
| | Environment |
| | Careers at Chemagis |
| | Contact Us |
|
|
| | | | | Lamotrigine | |
| Availability |
API |
| Molecular Formula |
C9H7Cl2N5 |
| IUPAC Nomenclature |
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine |
| Therapeutic Category |
Antiepileptic for partial seizures and secondarily generalised tonic-clonic seizures |
| CAS Number |
84057-84-1 |
| Presentation |
Europe: 25/50/100 mg tablets; 5/25/100 mg dispersible tabs
US: 25/100/150/200 mg tablets |
| Brand Name |
Lamictal |
| Inventor |
Glaxo-Wellcome |
| Patents |
Preparation process US 6,329,521 | |
|
| |
|
